Your browser doesn't support javascript.
loading
Modular Platform for the Development of Recombinant Hemoglobin Scavenger Biotherapeutics.
Buzzi, Raphael M; Owczarek, Catherine M; Akeret, Kevin; Tester, Andrea; Pereira, Natasha; Butcher, Rebecca; Brügger-Verdon, Valérie; Hardy, Matthew P; Illi, Marlies; Wassmer, Andreas; Vallelian, Florence; Humar, Rok; Hugelshofer, Michael; Buehler, Paul W; Gentinetta, Thomas; Schaer, Dominik J.
Affiliation
  • Buzzi RM; Division of Internal Medicine, Universitätsspital and University of Zurich, Zurich 8091, Switzerland.
  • Owczarek CM; CSL Limited, Bio21 Institute, Parkville, Victoria 3010, Australia.
  • Akeret K; Department of Neurosurgery, Clinical Neuroscience Center, Universitätsspital und University of Zurich, Zurich 8091, Switzerland.
  • Tester A; CSL Limited, Bio21 Institute, Parkville, Victoria 3010, Australia.
  • Pereira N; CSL Limited, Bio21 Institute, Parkville, Victoria 3010, Australia.
  • Butcher R; CSL Limited, Bio21 Institute, Parkville, Victoria 3010, Australia.
  • Brügger-Verdon V; Research and Development, CSL Behring AG, Bern 3014, Switzerland.
  • Hardy MP; CSL Limited, Bio21 Institute, Parkville, Victoria 3010, Australia.
  • Illi M; Research and Development, CSL Behring AG, Bern 3014, Switzerland.
  • Wassmer A; Research and Development, CSL Behring AG, Bern 3014, Switzerland.
  • Vallelian F; Division of Internal Medicine, Universitätsspital and University of Zurich, Zurich 8091, Switzerland.
  • Humar R; Division of Internal Medicine, Universitätsspital and University of Zurich, Zurich 8091, Switzerland.
  • Hugelshofer M; Department of Neurosurgery, Clinical Neuroscience Center, Universitätsspital und University of Zurich, Zurich 8091, Switzerland.
  • Buehler PW; Department of Pathology, The University of Maryland School of Medicine, Baltimore, Maryland 21201, United States.
  • Gentinetta T; The Center for Blood Oxygen Transport and Hemostasis, Department of Pediatrics, The University of Maryland School of Medicine, Baltimore, Maryland 21201, United States.
  • Schaer DJ; Research and Development, CSL Behring AG, Bern 3014, Switzerland.
Mol Pharm ; 18(8): 3158-3170, 2021 08 02.
Article in En | MEDLINE | ID: mdl-34292741
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Biological Products / Recombinant Fusion Proteins / Haptoglobins / Hemoglobins / Hemopexin / Drug Design Type of study: Prognostic_studies Limits: Animals / Humans Language: En Journal: Mol Pharm Journal subject: BIOLOGIA MOLECULAR / FARMACIA / FARMACOLOGIA Year: 2021 Document type: Article Affiliation country:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Biological Products / Recombinant Fusion Proteins / Haptoglobins / Hemoglobins / Hemopexin / Drug Design Type of study: Prognostic_studies Limits: Animals / Humans Language: En Journal: Mol Pharm Journal subject: BIOLOGIA MOLECULAR / FARMACIA / FARMACOLOGIA Year: 2021 Document type: Article Affiliation country: